AstraZeneca
Website:
AstraZeneca
Index:
FTSE 100
EPIC: AZN
Supersector:
Health Care
Sector:
Pharmaceuticals and Biotechnology
Subsector:
Pharmaceuticals
Market Cap:
£208.48B
Payout Frequency: Semi-Annual
AstraZeneca Annual Dividend Yield - 1.72%
Dividends Used in Calculation:
| Ex-Dividend Date |
Payment Date |
Type |
Amount |
Currency |
| 20/02/2025 |
24/03/2025 |
2nd Interim |
210.00¢ |
USX |
| 07/08/2025 |
08/09/2025 |
1st Interim |
103.00¢ |
USX |
Total (Annual Dividends Per Share):
234.37p
(Using exchange rate on 12/12/2025
$ = £0.74878)
Dividend Yield =
Annual Dividends Per Share (234.37p)
÷ Share Price (13612p)
= 1.72%
AstraZeneca Dividend History
| Ex Dividend Date |
Payment Date |
Type |
Amount |
Currency |
| 07/08/2025 |
08/09/2025 |
1st Interim |
103.00¢ |
USX |
| 20/02/2025 |
24/03/2025 |
2nd Interim |
210.00¢ |
USX |
| 08/08/2024 |
09/09/2024 |
1st Interim |
100.00¢ |
USX |
| 22/02/2024 |
25/03/2024 |
2nd Interim |
197.00¢ |
USX |
| 10/08/2023 |
11/09/2023 |
1st Interim |
93.00¢ |
USX |
| 23/02/2023 |
27/03/2023 |
2nd Interim |
197.00¢ |
USX |
| 11/08/2022 |
12/09/2022 |
1st Interim |
93.00¢ |
USX |
| 24/02/2022 |
28/03/2022 |
2nd Interim |
197.00¢ |
USX |
| 12/08/2021 |
13/09/2021 |
1st Interim |
90.00¢ |
USX |
| 25/02/2021 |
29/03/2021 |
2nd Interim |
190.00¢ |
USX |
| 13/08/2020 |
14/09/2020 |
1st Interim |
90.00¢ |
USX |
| 27/02/2020 |
30/03/2020 |
2nd Interim |
190.00¢ |
USX |
| 08/08/2019 |
09/09/2019 |
1st Interim |
90.00¢ |
USX |
| 08/08/2019 |
09/09/2019 |
Interim |
90.00¢ |
USX |
| 28/02/2019 |
27/03/2019 |
2nd Interim |
190.00¢ |
USX |
| 09/08/2018 |
10/09/2018 |
1st Interim |
90.00¢ |
USX |
| 15/02/2018 |
19/03/2018 |
2nd Interim |
190.00¢ |
USX |
| 10/08/2017 |
11/09/2017 |
1st Interim |
90.00¢ |
USX |
| 16/02/2017 |
20/03/2017 |
2nd Interim |
190.00¢ |
USX |
| 11/08/2016 |
12/09/2016 |
1st Interim |
90.00¢ |
USX |
| 17/02/2016 |
21/03/2016 |
2nd Interim |
190.00¢ |
USX |
| 13/08/2015 |
14/09/2015 |
1st Interim |
90.00¢ |
USX |
| 19/02/2015 |
23/03/2015 |
2nd Interim |
190.00¢ |
USX |
| 13/08/2014 |
15/09/2014 |
1st Interim |
90.00¢ |
USX |
| 19/02/2014 |
24/03/2014 |
2nd Interim |
190.00¢ |
USX |
| 14/08/2013 |
16/09/2013 |
1st Interim |
90.00¢ |
USX |
| Year |
Interim |
Currency |
Total |
Change |
| 2024 |
|
USX |
297.000 |
2.410 |
| 2023 |
|
USX |
290.000 |
0.000 |
| 2022 |
|
USX |
290.000 |
3.570 |
| 2021 |
|
USX |
280.000 |
0.000 |
| 2020 |
|
USX |
280.000 |
-24.320 |
| 2019 |
90.000 |
USX |
370.000 |
32.140 |
| 2018 |
|
USX |
280.000 |
0.000 |
| 2017 |
|
USX |
280.000 |
0.000 |
| 2016 |
|
USX |
280.000 |
0.000 |
| 2015 |
|
USX |
280.000 |
0.000 |
| 2014 |
|
USX |
280.000 |
211.110 |
| 2013 |
|
USX |
90.000 |
|
AstraZeneca Dividend Calculator
AstraZeneca Dividend Growth
| Dividend Growth (1Y) |
4.75%
|
| Dividend CAGR (5Y) |
3.4%
|
| Years of Growth |
–
|
| Payout Ratio |
52.89%
|
| Buyback Yield |
0.08%
|
| Shareholder Yield |
1.86%
|
| P/E Ratio (TTM) | 30.03 |
|---|
| Forward P/E | 17.77 |
|---|
| P/FCF | 22.14 |
|---|
| Earnings Yield | 3.35% |
|---|
| FCF Yield | 4.52% |
|---|
| ROE | 21.67% |
|---|
| ROCE | 19.78% |
|---|
| Profit Margin | 16.17% |
|---|
| Operating Margin | 27.37% |
|---|
| Gross Margin | 83.26% |
|---|